LK
LEE KENNETH B JR Other
US US · SEC (Form 4)
€38,475
▲ Purchases (3 ops.)
Discover the full record of transactions filed by LEE KENNETH B JR. Officer active across 2 companies, notably Eyenovia, INC.. Cumulatively, 9 disclosures have been logged. Total volume traded: €38k. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 9 total
022,222 shares 0
Common Stock, par value $.0001
SEC:0001415889-22-006807:0 · 16 Jun 2022
012,866 shares 0
Common Stock
SEC:0001127602-22-017144:0 · 7 Jun 2022
€20,796 10,000 shares @ €2.0796 54.1% of flow
Common Stock, par value $.0001
SEC:0001415889-22-005467:0 · 19 May 2022
Ideal exit: 13 Feb 2023 (T+270) 06,963 shares 0
Common Stock, par value $.0001
SEC:0001415889-21-005357 · 17 Nov 2021
06,963 shares 0
Common Stock, par value $.0001
SEC:0001415889-21-005357:0 · 17 Nov 2021
€40,891 15,000 shares @ €2.7261 0.0025% mcap 100.0% of flow
Common Stock
SEC:0001127602-21-025331 · 13 Sept 2021
€40,891 15,000 shares @ €2.7261 0.0025% mcap 50.0% of flow
Common Stock
SEC:0001127602-21-025331:0 · 13 Sept 2021
€8,840 2,000 shares @ €4.4198 100.0% of flow
Common Stock, par value $.0001
SEC:0001638599-21-000551 · 11 Jun 2021
Ideal exit: 8 Mar 2022 (T+270) €8,840 2,000 shares @ €4.4198 23.0% of flow
Common Stock, par value $.0001
SEC:0001638599-21-000551:0 · 11 Jun 2021
Ideal exit: 8 Mar 2022 (T+270) About LEE KENNETH B JR Kenneth B Jr Lee is a director at Eyenovia, INC. and is also associated with Biocryst Pharmaceuticals INC.